EP 1968645 A2 20080917 - HUMAN GLP-1 MIMETIBODIES AND COMPOSITIONS FOR TREATING OBESITY AND RELATED DISORDERS, METHODS AND USES
Title (en)
HUMAN GLP-1 MIMETIBODIES AND COMPOSITIONS FOR TREATING OBESITY AND RELATED DISORDERS, METHODS AND USES
Title (de)
HUMANE GLP-1-MIMETIKÖRPER UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ADIPOSITAS UND VERWANDTER ERKRANKUNGEN, VERFAHREN UND ANWENDUNGEN
Title (fr)
CORPS MIMETIQUES HUMAINS GLP-1 ET COMPOSITIONS POUR TRAITER L'OBESITE ET LES TROUBLES ASSOCIES, PROCEDES ET UTILISATIONS
Publication
Application
Priority
- US 2006062223 W 20061218
- US 75282605 P 20051222
Abstract (en)
[origin: WO2007076319A2] The present invention relates to at least one novel human GLP-1 mimetibody or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 mimetibody or specified portion or variant, GLP-1 mimetibody or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices for treating obesity related disorders.
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/04 (2006.01); C07K 5/00 (2006.01)
CPC (source: EP)
A61K 38/26 (2013.01); A61K 47/6811 (2017.07); A61K 47/6849 (2017.07); A61P 3/04 (2017.12); A61K 48/00 (2013.01); C07K 2319/30 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007076319 A2 20070705; WO 2007076319 A3 20081030; CA 2634784 A1 20070705; EP 1968645 A2 20080917; EP 1968645 A4 20091104; JP 2009526750 A 20090723
DOCDB simple family (application)
US 2006062223 W 20061218; CA 2634784 A 20061218; EP 06846650 A 20061218; JP 2008547703 A 20061218